Figures & data
Table 1 Association Between Genetic and Prediction of T2DM
Figure 2 Impairments in the regulation of insulin and glucose may cause an increase in hepatic FTO expression.
![Figure 2 Impairments in the regulation of insulin and glucose may cause an increase in hepatic FTO expression.](/cms/asset/099aa22e-df97-481f-8094-5b2efd9a922a/dmso_a_230061_f0002_c.jpg)
Figure 3 Transcription factor network in the pancreatic β-cell.
![Figure 3 Transcription factor network in the pancreatic β-cell.](/cms/asset/565e8302-97e4-4e7c-8594-4ddfcf41a3c9/dmso_a_230061_f0003_c.jpg)
Figure 4 Probable mechanism of CKN2A/B-antisense noncoding RNA in the INK4 locus (ANRIL) gene product.
![Figure 4 Probable mechanism of CKN2A/B-antisense noncoding RNA in the INK4 locus (ANRIL) gene product.](/cms/asset/deb67567-87a7-4bb8-af22-effd3ac6cec2/dmso_a_230061_f0004_c.jpg)
Figure 5 Possible role of TCF7L2 in the pathogenesis of T2DM.
![Figure 5 Possible role of TCF7L2 in the pathogenesis of T2DM.](/cms/asset/9659c8d3-5369-4e17-8d6c-82ce5299f37f/dmso_a_230061_f0005_c.jpg)
Figure 6 Mechanism of insulin secretion by the KATP channel in pancreatic β-cells. SUR1 and Kir6.2 proteins in the KATP channel mediate insulin secretion.
![Figure 6 Mechanism of insulin secretion by the KATP channel in pancreatic β-cells. SUR1 and Kir6.2 proteins in the KATP channel mediate insulin secretion.](/cms/asset/a5bdb988-eecd-4721-812f-a263cd5b3c2a/dmso_a_230061_f0006_c.jpg)
Figure 7 Interaction between ZnT8 expression (A) low ZnT8 and (B) high ZnT8, hormone action, and hepatic insulin clearance.
![Figure 7 Interaction between ZnT8 expression (A) low ZnT8 and (B) high ZnT8, hormone action, and hepatic insulin clearance.](/cms/asset/b4252995-9b26-495b-a0fd-cbd7439cb899/dmso_a_230061_f0007_c.jpg)